Fortress Biotech
在场
Fortress Biotech 是一家在股票代码 FBIO (US) 下上市的公司。
Fortress Biotech 拥有 4家子公司，其中包括 Avenue Therapeutics、Checkpoint Therapeutics 和 Journey Medical Corp。
他们在：
高管
查看带有其 52 名主要高管的组织结构图
Fortress Biotech 搜索最多的简介
- Lindsay Rosenwald, Chairman, President, and Chief Executive Officer
- Jay Lobell, Director
- Malcolm Hoenlein, Director
创建提醒
跟踪 Fortress Biotech 的高管变动
生物技术
Fortress Biotech 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
Fortress Biotech 的最新新闻稿
- Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
- Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
- Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
- Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
- Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
- Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
- Fortress Biotech to Participate in October 2024 Investor Conferences
- Press Releases
- Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
- Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements
- View more press releases Close
通过电子邮件
